Trial intelligence / Profile preview

Tinzaparin vs Heparin in Diabetic Hemodialysis Patients

NCT00407641Phase 4Withdrawn

Sponsor
Anemia Working Group Romania
Start
Mar 2009
Primary completion
Jan 2015
Modality
Recombinant Proteins and Enzymes
Countries
1
01

Overview

A Phase 4 trial of tinzaparin in cardiovascular disease (CVD), hyperlipidemia, sponsored by Anemia Working Group Romania. Planned start Mar 2009; status: withdrawn.

02

Drugs

tinzaparin
03

Conditions

cardiovascular disease (CVD)hyperlipidemia

Beyond the preview

Go deeper on NCT00407641.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00407641.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call